ALID Stock Overview
Allied Corp., a cannabis company, engages in the research, development, and production of cannabinoid health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Allied Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.16 |
| 52 Week High | US$0.32 |
| 52 Week Low | US$0.021 |
| Beta | -0.041 |
| 1 Month Change | 128.57% |
| 3 Month Change | 124.93% |
| 1 Year Change | -13.78% |
| 3 Year Change | -82.26% |
| 5 Year Change | n/a |
| Change since IPO | -89.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALID | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -4.0% | -0.6% | 1.0% |
| 1Y | -13.8% | 10.6% | 21.9% |
Return vs Industry: ALID underperformed the US Pharmaceuticals industry which returned 13.2% over the past year.
Return vs Market: ALID underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| ALID volatility | |
|---|---|
| ALID Average Weekly Movement | 40.1% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ALID's share price has been volatile over the past 3 months.
Volatility Over Time: ALID's weekly volatility (40%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Calum Hughes | allied.health |
Allied Corp., a cannabis company, engages in the research, development, and production of cannabinoid health solutions in the United States. The company offers hemp derived CBD natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummies under the Tactical Relief brand. It also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post activity rub for aches and pains; and Quick Hit, a CBD gummies with vitamin B12 under the Equilibrium Bio brand.
Allied Corp. Fundamentals Summary
| ALID fundamental statistics | |
|---|---|
| Market cap | US$16.42m |
| Earnings (TTM) | -US$9.00m |
| Revenue (TTM) | US$21.51k |
763.5x
P/S Ratio-1.8x
P/E RatioIs ALID overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALID income statement (TTM) | |
|---|---|
| Revenue | US$21.51k |
| Cost of Revenue | US$1.51m |
| Gross Profit | -US$1.49m |
| Other Expenses | US$7.52m |
| Earnings | -US$9.00m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.085 |
| Gross Margin | -6,919.56% |
| Net Profit Margin | -41,861.42% |
| Debt/Equity Ratio | -81.5% |
How did ALID perform over the long term?
See historical performance and comparison